Condensed Consolidated Statements of Changes in Stockholders' Equity (Deficit) (Unaudited) - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]	Total
Balance at Dec. 31, 2017	$ 1,007	$ 17,492,083	$ (18,102,618)	$ (609,528)
Balance (in shares) at Dec. 31, 2017	3,051,538
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock based compensation expense	$ 0	7,015	0	7,015
Capitalized offering costs	0	(44,000)	0	(44,000)
Issuance of common stock, net of issuance costs	$ 93	757,801	0	757,894
Issuance of common stock, net of issuance costs (in shares)	281,860
Warrant costs associated with stock issuance	$ 0	342,105	0	342,105
Net income (loss)	0	0	(737,892)	(737,892)
Balance at Mar. 31, 2018	$ 1,100	18,555,004	(18,840,510)	(284,406)
Balance (in shares) at Mar. 31, 2018	3,333,398
Balance at Dec. 31, 2017	$ 1,007	17,492,083	(18,102,618)	(609,528)
Balance (in shares) at Dec. 31, 2017	3,051,538
Balance at Dec. 31, 2018	$ 1,128	19,311,529	(21,013,174)	(1,700,517)
Balance (in shares) at Dec. 31, 2018	3,417,187
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock based compensation expense	$ 0	2,754,871	0	2,754,871
Issuance of common stock, net of issuance costs	$ 16	749,984	0	750,000
Issuance of common stock, net of issuance costs (in shares)	48,930
Issuance of common stock for antidilution	$ 32	(32)	0	0
Issuance of common stock for antidilution (in shares)	97,960
Issuance of common stock for convertible debt	$ 3	32,950	0	32,953
Issuance of common stock for convertible debt (in shares)	9,683
Equity from merger transaction	$ 528	15,793,109	0	15,793,637
Equity from merger transaction (in shares)	1,599,178
Net income (loss)	$ 0	0	6,816,698	6,816,698
Balance at Mar. 31, 2019	$ 1,707	$ 38,642,411	$ (14,196,476)	$ 24,447,642
Balance (in shares) at Mar. 31, 2019	5,172,938